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soluble (DMSO-soluble) snus and nicotine, the most important substance in tobacco, on the expression 
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Rat middle cerebral arteries were isolated and organ cultured in serum free medium for 24 h in the 
presence of water-soluble snus (WSS), DMSO-soluble snus (DSS), or nicotine. The dose of snus and 
nicotine was kept at plasma level of snus users (25 ng nicotine/ml). A high dose (250 ng nicotine/ml) 
was also included due to the previous results showing alteration in the GPCR expression by nicotine at 
this concentration. Contractile responses to the ETB receptor agonist sarafotoxin 6c, 5-HT1B receptor 
agonist 5-carboxamidotryptamine, and TP receptor agonist U46619 were investigated by a sensitive 
myograph. The expression of ETB, 5-HT1B, and TP receptors were studied at mRNA and protein levels 
using quantitative real time PCR and immunohistochemistry, respectively. 
Organ culture with WSS or DSS (25 ng nicotine/ml) lowered the 5-HT1B receptor mediated 
contraction. Furthermore, DSS shifted the TP receptor mediated contraction curve left-wards with a 
stronger contraction. High dose of nicotine (250 ng nicotine/ml) increased the ETB receptor mediated 
contraction. The combined 5-HT1B and 5-HT2A receptor mediated contraction was increased, and 
both the 5-CT and TxA2 induced contractions were left-ward shifted by WSS, DSS, or nicotine (250 ng 
nicotine/ml). Only the DSS group showed that the increase of 5-HT1B receptor mediated contraction 
occurred at the transcriptional level, demonstrated by an increased mRNA expression for the receptor. 
Snus and nicotine alter the GPCR expression in the cerebral arteries, suggesting that both snus and 
nicotine may have a potential impact on cerebral vasculature and on the development of 
cerebrovascular disease like stroke. 
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Abstract 
The cardiovascular risk for users of use of Swedish snus/American snuff (moist tobacco) has been 
debated for a long time. The present study was designed to examine the effects of water- or lipid-
soluble (DMSO-soluble) snus and nicotine, the most important substance in tobacco, on the 
expression of vasocontractile G-protein coupled receptors (GPCR), such as endothelin ETB, 
serotonin 5-HT1B, and thromboxane A2 TP receptors, in rat cerebral arteries. Studies show that 
these vasocontractile GPCR show alterations by lipid-soluble cigarette smoke particles via 
activation of mitogen-activated protein kinases (MAPK). However, the effects of moist tobacco on 
the expression of GPCR are less studied. 
*Manuscript Text
Click here to view linked References
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Rat middle cerebral arteries were isolated and organ cultured in serum free medium for 24 h in the 
presence of water-soluble snus (WSS), DMSO-soluble snus (DSS), or nicotine. The dose of snus 
and nicotine was kept at plasma level of snus users (25 ng nicotine/ml). A high dose (250 ng 
nicotine/ml) was also included due to the previous results showing alteration in the GPCR 
expression by nicotine at this concentration. Contractile responses to the ETB receptor agonist 
sarafotoxin 6c, 5-HT1B receptor agonist 5-carboxamidotryptamine, and TP receptor agonist 
U46619 were investigated by a sensitive myograph. The expression of ETB, 5-HT1B, and TP 
receptors were studied at mRNA and protein levels using quantitative real time PCR and 
immunohistochemistry, respectively. 
Organ culture with WSS or DSS (25 ng nicotine/ml) lowered the 5-HT1B receptor mediated 
contraction. Furthermore, DSS shifted the TP receptor mediated contraction curve left-wards with a 
stronger contraction. High dose of nicotine (250 ng nicotine/ml) increased the ETB receptor 
mediated contraction. The combined 5-HT1B and 5-HT2A receptor mediated contraction was 
increased, and both the 5-CT and TxA2 induced contractions were left-ward shifted by WSS, DSS, 
or nicotine (250 ng nicotine/ml). Only the DSS group showed that the increase of 5-HT1B receptor 
mediated contraction occurred at the transcriptional level, demonstrated by an increased mRNA 
expression for the receptor. 
Snus and nicotine alter the GPCR expression in the cerebral arteries, suggesting that both snus and 
nicotine may have a potential impact on cerebral vasculature and on the development of 
cerebrovascular disease like stroke. 
 
Keywords: Moist tobacco snus (snuff); nicotine; endothelin ETB receptor, serotonin 5-HT1B 
receptor; thromboxane A2 TP receptors, cerebral arteries. 
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1 Introduction  
The use of snus (moist tobacco) is an effective way for Swedes to quit/reduce smoking, and thus 
reduce health risks of burnt tobacco use. However, this occurs at a cost of local oral exposure and 
higher nicotine levels in the circulation. The toxic effects of using Swedish moist snus on cerebral 
and cardiovascular diseases have been debated for a long time. Clinical studies show that snus has; 
(i) mild side-effects on health like few  and occasional oral lesions (Andersson et al., 1994), (ii) 
moderate side-effects such as elevated blood pressure (Bolinder et al., 1992), (iii) rarely, 
modification of cerebral and cardiovascular diseases, and (iv) seldom larynx/oesophagus cancers 
(US Department of Health and Human Services, 1986). However, specific and detailed 
pharmacological studies on snus effects on cerebral arteries are absent.  
 
Nicotine is the addictive substance in snus. In order to reveal possible molecular mechanisms of 
snus, which could lead to development of cerebrovascular disease, we examined if snus extracts or 
nicotine could alter GPCR expression and function of contraction in rat cerebral arteries (Hansen-
Schwartz et al., 2002;Hoel et al., 2001).  
 
GPCR-mediated vascular smooth muscle contraction, proliferation and apoptosis are important 
events in the pathogenesis of cerebral and cardiovascular disease (Hansen-Schwartz et al., 2003b). 
Organ culture of cerebral vessels has been demonstrated as an in vitro method  for exploring the 
molecular mechanisms that lead to changes in GPCR (endothelin type B receptor (ETB), 5-
hydroxytryptamine type 1B receptor (5-HT1B), and thromboxane A2 prostanoid receptor (TP)) 
expression in a way resembling that observed in cerebral ischemia in vivo (Hoel et al., 
2001;Rosamond et al., 2008;Hansen-Schwartz et al., 2002;Henriksson et al., 2003). All these three 
receptors belong to the GPCR family and mediate cerebral vascular contraction and smooth muscle 
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cell proliferation (Coleman et al., 1994;Masaki et al., 1994;Nilsson et al., 1999) and have been 
observed to be upregulated after a stroke and after organ culture. 
 
The present study has examined the effects of snus and nicotine at plasma level which resemble that 
seen in snus users (25 ng nicotine/ml) (Benowitz et al., 1994;Foulds et al., 2003). A high dose was 
also included (250 ng nicotine/ml) due to previous studies showing that higher doses of nicotine 
may influences GPCR expression (Zhang et al., 2009). “Normal” plasma level of nicotine of WSS, 
DSS, or nicotine does not affect the receptor expression of endothelin ETB. Serotonin 5-HT1B and 
5-HT2A mediated contraction curve was lowered by WSS and DSS (normal plasma level), while 
DSS also left-ward shifted the TP mediated contraction curve. The high dose of nicotine of WSS, 
DSS, or nicotine enhanced the contraction by 5-HT1B and 5-HT2A and TP. High nicotine level 
increased the endothelin ETB receptor mediated contraction curve. The alteration of GPCR 
expression in the cerebral arteries by snus and nicotine most likely is a molecular mechanism 
involving cerebral vascular damage. Thus, this suggests that snus and nicotine may have a potential 
impact on development of cerebrovascular disease.    
 
2 Materials and Methods  
2.1 Removal of cerebral vessels and organ culture  
Studies were approved by the Danish Animal Experiments Committee guidance (no. 2006/561-
1139). Male Sprague-Dawley rats (n = number of rats = 78; 300-350 g) (Taconic, Denmark) were 
sedated with 70 % CO2 in O2 and decapitated while unconscious. The brains were removed and 
immediately chilled in ice-cold Na+-Krebs buffer solution (for composition see below). The right 
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and left middle cerebral arteries were isolated and dissected free of adhering tissue in ice-cold Na+-
Krebs buffer. 
 
Middle cerebral artery segments (1.5 – 3.0 mm long), rings with intact endothelium, were incubated 
for 24 hrs at 37 °C in humidified 5 % CO2 and 95 % air in serum free Dulbecco’s modified Eagle’s 
medium (DMEM: 1 mg/ml glucose, 4mM L-glutamine, 0.11 mg/ml sodium pyruvate) 
supplemented with an antibiotics mix (10.000 units/ml of penicillin, 10 mg/ml of streptomycin, and 
25 ng/ml of amphotericin B). Each middle cerebral artery was bluntly cut into 4-5 segments, each 
2.0 – 3.0 mm long (all in all 8 – 10 segments per rat) for the myograph bath studies. For real time 
PCR and immunohistochemistry studies the middle cerebral artery was dived into 2 segments, each 
6.0 – 7.0 mm long (all in all 4 segments per rat). Middle cerebral artery segments from the rat were 
used in myograph bath studies for different groups. For real time PCR and immunohistochemistry 
experiments middle cerebral artery segments were used for both methods. The anatomical portion 
of middle cerebral artery segments for myograph bath, real time PCR and immunohistochemistry 
studies were interchanged (n values for each group: myograph bath n = 6-10, real time PCR n = 6-7, 
and immunohistochemistry n = 4-5). Fresh or organ cultured cerebral artery ring segments were 
either mounted in myographs for in vitro pharmacology or snap-frozen with dry ice and kept at -80 
°C for real time PCR or immunohistochemistry. 
 
WSS or DSS was added to the DMEM medium at the initiation of the incubation. Vehicle (water or 
DMSO) was added as control. All organ culture experiments were performed for the duration of 24 
h. Water, DMSO, WSS, DSS, or nicotine were added at 0 h, giving a total duration of 24 h. The 
final volume of DMSO added to the 1 ml DMEM was always kept at 1 µl.  
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2.2 Drugs 
Dulbecco’s modified Eagle’s medium (DMEM: 1 mg/ml glucose, 4 mM L-glutamine, 0.11 mg/ml 
sodium pyruvate), antibiotics mix (10,000 units/ml penicillin, 10,000 µg/ml streptomycin, and 25 
µg/ml amphotericin), and Trizol were from Invitrogen, USA. 1-Bromo-3-chloropropane, dimethyl 
sulfoxide (DMSO), carbachol, 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), 
U46619, absolute ethanol, nicotine and other high grade chemicals were purchased from Sigma-
Aldrich, USA. Sarafotoxin 6c was from NeoMPS S.A., France. RNase free water was from Qiagen, 
USA. 
 
2.3 Extraction of water- or DMSO-soluble snus solution (WSS or DSS) 
Bags of snus (General brand, Swedish Match # 0200-113114, batch # 52030-462-1) were dissolved 
for 1 hr at 37 °C in either water or DMSO (tubes were vortexed every 15 min). The Swedish Match 
company informed that the pH was 8.5 and the nicotine content was 8 mg/gram snus. Snus bags 
were weighted before dissolving in water or DMSO, and the final concentrations were 250 ng 
nicotine / µl (this was diluted ten-times to give a 25 ng nicotine / µl solution also). One µl of these 
solutions were added to 1 ml DMEM media for organ culture, giving a final concentration of 25 or 
250 ng nicotine pr. ml of DMEM. Keeping in mind that nicotine is water soluble, snus was 
dissolved in DMSO (DSS) in the same way as it was in water. 
 
A previous study has revealed that high doses of nicotine (480 ng/ml and 960 ng/ml) may affect 
contractions mediated by endothelin ETB and 5-HT1B receptor in rat mesenteric arteries (Zhang et 
al., 2009). The Emax of the endothelin ETB receptor mediated contraction induced by the specific 
agonist S6c is increased dramatically by 2-fold when 480 ng/ml nicotine was added to the organ 
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culture, whereas 960 ng/ml nicotine gave a 3-fold increase in E
max
. The 5-HT curve was right-ward 
shifted (increase in pEC50) by 60 ng/ml and 960 ng/ml nicotine. This shows that a higher dose of 5-
HT is needed to promote the same 5-HT receptor mediated contraction, which could be due to 
fewer 5-HT receptors or lower receptor affinity. 
 
The high doses of nicotine (480 ng/ml and 960 ng/ml) are about 20-40 times higher than that 
observed in plasma of snus users and does not have any clinical importance (only a toxic dose); 
hence, we chose to examine more reasonable doses of 250 ng/ml.  
 
2.4 In vitro pharmacology 
A sensitive myograph was used to record the isometric tension in isolated cerebral vessel segments 
(Hogestatt et al., 1983;Mulvany et al., 1977). The vessel segments were threaded on two 40 µm-
diameter stainless steel wires and mounted on a Mulvany-Halpern myograph (Danish Myo 
Technology A/S, Denmark). One of the wires was connected to a force displacement transducer 
attached to an analog-digital converter unit (PowerLab from ADInstruments, New Zealand), while 
the other wire was attached to a movable displacement device allowing fine adjustments of vascular 
tension by varying the distance between the two wires. The measurements were recorded on a 
computer using the software Chart 5.4.2 (ADInstruments, U.K.).  
 
The segments were immersed into a temperature-controlled (37 °C) Na+-Krebs buffer solution 
(composition in mM/ml; NaCl = 119, NaHCO3 = 15, KCl = 4.6, MgCl2 = 1.2, NaH2PO4 = 1.2, 
CaCl2 = 1.5, and glucose = 5.5). The buffer was continuously gassed with 5 % CO2 in O2 resulting 
in a physiological pH at 7.4. The vessels were given an initial pre-tension of 2 mN/mm and were 
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adjusted to this tension for 1 hour. Contractile capacity was determined by exposed to rich 
potassium (60 mM K+-Krebs) buffer solution with the same composition as the Na+-Krebs buffer 
solution except that NaCl was exchanged for KCl. The threshold for minimum 60 mM K+-
contraction response was set to 1.0 mN (if the K+-contraction was lower, the data from the vessel 
was discarded).  
 
The dilatation induced by carbachol after 5-HT mediated contraction was used as measurement of 
endothelium functionality. Carbachol mediates an endothelium dependent dilation of vessels via 
release of nitric oxide. Middle cerebral artery segments were pre-contracted with 300 nM 5-HT and 
subsequently exposed to 10 µM carbachol. A strong dilation by carbachol indicated intact 
functional endothelium, whereas a weak or absent dilation indicates damaged or unfunctional 
endothelium (i.e. due to mechanical damage of the endothelium during mounting on wires). 
Concentration-response curves were subsequently obtained by cumulative application of the 
agonist: endothelin ETB receptor specific agonist S6c (10-14 M to 10-7 M), serotonin 5-HT1B 
agonist 5-CT (10-12 M to 10-4 M), or prostanoid TP receptor specific agonist U46619 (10-12 M to 
10-5 M). Specificity of detailed receptor charactering has been performed before (Henriksson et al., 
2003;Sandhu et al., 2010a). 
 
2.5 Molecular Biology  
The middle cerebral artery segments were removed and snap-frozen with dry ice in green-cap tubes 
containing Lysing Matrix D provided in the FastRNA Pro Green Kit (Q Biogene, USA). Total 
cellular RNA was extracted using the FastRNA Pro Green Kit. The vessels were homogenized in 1 
ml of Trizol Solution by using a FastPrep FP120 instrument (Q Biogene, USA). The samples were 
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centrifuged for 15 min at 4 °C at 12,500 g, and the liquid phase was transferred to 300 µl of 1-
bromo-3-chloropropane. After centrifugation the upper phase was transferred to 500 µl of 100 % 
isopropanol and stored at -20 °C overnight. Next day the samples were centrifuged for 20 min at 4 
°C at 15,000 g and the supernatant was removed. The pellet was washed with 500 µl 75 % ethanol, 
air dried and re-dissolved with RNase free water. Total RNA amount and purity was determined 
using NanoDrop 2000c (Thermo Science, USA).  
 
Reverse transcription of total RNA to cDNA was performed with the TaqMan Reverse 
Transcription Reagents (Applied Biosystems, USA) in a GeneAmp PCR System 2400 (Perkin-
Elmer, USA). First-strand cDNA was synthesized from 250 ng total RNA in a 20 µl reaction 
volume with random hexamers used as primers. The reverse transcription reaction was performed 
with the following setup: 42 °C for 90 min followed by 72 °C for 10 min. The cDNA was diluted 
with 30 µl of RNase free water when used in the real time PCR reaction. 
 
Real time PCR was performed in a 7500 Fast Real Time PCR sequence detection system (Applied 
Biosystems, USA) with the SYBR Green PCR Master Mix (Applied Biosystems, USA) with 1 µl 
cDNA synthesized above as template in a 25-µl reaction volume. A none-template control was 
included in all experiments. Primer (1 µl of 10 mM) was added to the 25 µl real time PCR reaction. 
Elongation factor-1 (EF-1) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA were 
used as references genes because they are the product of housekeeping genes and are therefore 
continuously expressed to a constant amount in cells. Specific primers for the rat endothelin ETB 
receptor, serotonin 5-HT1B receptor, prostanoid TP receptor, EF-1, and GAPDH receptors were 
designed (ETB receptor primers (NM_017333): forward 5'-CCCGAGCGAACTGCTGAGGATC-3' 
and reverse 5'-TGCCTTAGGGGGCTTTCGGC-3'; 5-HT1B receptor primers (NM_022225): 
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forward 5’-TCCGGGTCTCCTGTGTACGT-3’ and reverse 5’-GGCGTCTGAGACTCGCACTT-
3’; TP receptor primers (NM_017054): forward 5’-ATCTCCCATCTTGCCATAGTCC–3’ and 
reverse 5’-CGATGATCCTTGGAGCCTAAAG-3’; EF-1 primers (NM_175838): forward 5'-
CGCAACGGGTTTGCCGTCAG-3' and reverse 5'-AGTCAGCCTGAGATGTGCCCGT-3'; 
GAPDH primers (NM_017008): forward 5′-GGGCTCTCTGCTCCTCCCTGTT-3′ and reverse 5′-
CACACCGACCTTCACCATCTTGTC-3′). 
 
The real time PCR was performed with the following profile: 50°C for 2 minutes and 95°C for 10 
minutes, followed by 40 cycles with 95°C for 15 seconds and 60 °C for 1 minute.  
 
The 7500 Fast Real Time PCR sequence detection software SDS version 1.4 (Applied Biosystems, 
USA) monitors the growth of DNA in real time by optics and imaging system via the binding of a 
fluorescent dye to double-stranded DNA.  
 
2.6 Immunohistochemistry 
The middle cerebral artery was dissected out and then placed into Tissue TEK (Sakura Finetek 
Europe B.V., Netherlands) and frozen. Segments were sectioned into 10-µm-thick slices and 
mounted on SuperFrost Plus slides (Menzel GMBH & COKG, Germany). 
 
The primary antibodies used were sheep anti-rat endothelin ETB receptor
 (ALX-210-506A, Alexis, 
USA), diluted 1:250; rabbit anti-rat serotonin 5-HT1B receptor (ab13896, Abcam, UK), diluted 
1:500; rabbit anti-rat prostanoid TP receptor (ab65150, Abcam, UK), diluted 1:200; and mouse anti-
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rat actin (ab11003, Abcam, UK), diluted 1:500. All the dilutions were done in phosphate buffered 
saline with 2 % donkey serum (017-000-121, Jackson ImmunoResearch laboratories, Inc., USA).
 
 
The secondary antibodies used were donkey anti-sheep DL488 conjugated (713-485-003, Jackson 
ImmunoResearch laboratories, Inc., USA), diluted 1:200; donkey anti-rabbit DL488 conjugated 
(711-485-152, Jackson ImmunoResearch laboratories, Inc., USA), diluted 1:200; and donkey anti-
mouse DL549 conjugated (715-505-150, Jackson ImmunoResearch laboratories, Inc., USA), diluted 
1:200. As control, only secondary antibodies were used. 
 
The antibodies were detected at the appropriate wavelength on a confocal microscopy (Nikon,  
C1plus, Nikon Instruments Inc., USA).  
 
2.7 Calculation and statistical analyses  
Data are expressed as mean values ± standard error of the mean (S.E.M.), and n refers to the 
number of rats. Statistical analyses of myograph data were performed on Emax- or pEC50-values 
with one way ANOVA with Bonferroni’s test, and selected groups were compared. When analyzing 
real time PCR data mRNA levels relative to the reference gene was used, and fluorescence mean 
intensities values were analyzed for the immunohistochemistry data.  
 
Groups compared in ANOVA test: 24 h organ culture with vehicle (water or DMSO) vs. fresh, or 
24 h organ culture with vehicle vs. 24 h organ culture with 25 or 250 ng/ml WSS / DSS / Nicotine. 
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Statistical information is given in Table 2. P< 0.05 was considered statistically significant (P< 
0.05=*, P< 0.01=**, P< 0.001=***). 
 
2.7.1 In vitro Pharmacology 
Contractile responses in each segment are expressed as percentage of the 60 mM K+ induced 
contraction. E
max 
value represents the maximum contractile response elicited by an agonist and the 
pEC50 the negative logarithm of the drug concentration that elicited half the maximum response. For 
biphasic responses, E
max(1) and pEC50(1) describes the low affinity phase and Emax(2) and pEC50(2)) 
describes the high affinity phase.   
 
2.7.2 Real time PCR 
 
Data were analysed with the comparative cycle threshold (CT) method (Hansen-Schwartz et al., 
2002). The CT values of EF-1 or GAPDH mRNA were used as a reference to quantify the relative 
amount of endothelin ETB receptor, serotonin 5-HT1B receptor, and prostanoid TP receptor mRNA. 
The relative amount of mRNA was calculated with the CT values of endothelin ETB receptor, 
serotonin 5-HT1B receptor, and prostanoid TP receptor mRNA in relation to the CT values of EF-1 
or GAPDH mRNA in the sample by the formula X0/R0=2CtR-CtX, where X0 is the original amount of 
target mRNA, R0 is the original amount of EF-1 or GAPDH mRNA, CtR is the CT value for EF-1 or 
GAPDH, and CTX is the CT value for the target. Data with EF-1 as the reference gene is shown in 
results section.
 
 
2.7.3 Immunohistochemistry 
 
Images were analyzed by Nikon EZ-C1 software version 3.70. Fluorescence intensity was measured 
on the whole smooth muscle cell area in 3 sections using the entire circumfence; the mean of this 
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was used. Actin staining was used as reference of smooth muscle cell localization. Analysis was 
done by having the red 549 nm channel (actin conjugated) overlay. 
 
3 Results  
The effects of WSS, DSS, and nicotine were studied in organ culture at the initiation of incubation 
for 24 h. WSS is the solution containing both snus ingredients and nicotine, while DSS is the 
solution only containing the lipid-soluble snus ingredients. Together both two solutions along with 
pure nicotine provides an overall representation of what snus contains, and experimental results 
show what effect the snus ingredients + nicotine, snus ingredients, or nicotine have on the GPCR.  
The acute administration of WSS, DSS, and nicotine on resting fresh artery segments produced no 
vasomotor response (data not shown). 
 
3.1 Endothelial functions 
Carbachol (10 µM) elicited dilatation of the 5-HT (300 nM) pre-contracted middle cerebral artery 
segments by 52 ± 10 % of pre-contraction in fresh middle cerebral vessels. After 24 h of organ 
culture the dilatation induced by carbachol was 28 ± 8 % (with water), and 27 ± 2 % (with DMSO) 
(p>0.05 for both organ culture types compared to fresh vessels); organ culture nominally reduced 
the endothelial function. Co-incubation with WSS, DSS, or nicotine (25 ng/ml or 250 ng/ml) did 
not alter the carbachol-induced dilatation compared to organ culture with vehicle (see Table 2 for 
all carbachol mediated dilatation values). 
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3.2 GPCR expression 
Addition of 60 mM K+-induced stable and reproducible contraction of the smooth muscle cells and 
was used as internal reference (set as 100 %). Incubation for 24 h with vehicle (water or DMSO) 
did not alter the 60 mM K+ responses (60 mM K+ response in mN: fresh = 4.39 ± 1.45, organ 
culture with water = 4.18 ± 1.75, and organ culture with DMSO = 3.84 ± 1.64).  
 
3.2.1 Endothelin ETB receptors 
The endothelin ETB receptor mediated contraction was strongly increased by the organ culture 
(Emax in % of 60 mM K+: fresh = 5 ± 1, organ culture with water = 111 ± 6, and organ culture with 
DMSO = 80 ± 12; p<0.001) (Figure 1A, 1D, 1G, Table 2). Real time PCR and 
immunohistochemistry showed significant upregulation of endothelin ETB receptors at mRNA and 
protein levels (Figure 2A, 2D, 2G, 3A, 3D, and 3G), thus, the increase in the endothelin ETB 
receptor mediated contraction occurred at the transcriptional level. The endothelin ETB receptor 
mediated contraction in the DMSO vehicle group is slightly lower than that seen in the water 
vehicle group. The S6c pEC50 values did not differ between the two vehicle groups. 
 
3.2.2 5-HT receptors 
Addition of 5-CT resulted in a biphasic sigmoid curve. This concentration-effect curve was only 
slightly increased by organ culture (E
max(1) and Emax(2) in % of 60 mM K+: fresh = 5 ± 2 and 52 ± 
14, organ culture with water = 4 ± 1  and 60 ± 6, and organ culture with DMSO = 8 ± 4 and 64 ± 7) 
(Figure 1B, 1E, 1H, Table 2). The mRNA expression of the 5-HT1B receptor was however 
upregulated significantly by organ culture (Figure 2B, 2E, 2H, p<0.001), and so was the 5-HT1B 
receptor protein level (Figure 3B, 3E, 3H, p<0.01 or p<0.05). This suggests that the slight increase 
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in contraction is mediated by production of 5-HT1B receptors. The 5-CT Emax(1) and Emax(2) or the 
5-CT pEC50(2)  values did not change in the two vehicle groups. 
 
3.2.3 TP receptors 
The U46619 induced contraction was not altered significantly by organ culture (Emax in % of 60 
mM K+: fresh = 152 ± 13, organ culture with water = 161 ± 12, and organ culture with DMSO = 
137 ± 9) (Figure 1C, 1F, 1I, Table 2). In accord, neither mRNA nor protein levels of TP receptors 
were changed by organ culture (Figure 2C, 2F, 2I, 3C, 3F, 3I). The U46619 E
max
 or the U46619 
pEC50 values did not differ between the two vehicle groups. 
 
3.3 Effects of snus or nicotine on the receptor expression 
3.3.1 Water soluble snus (WSS) 
The WSS incubation experiments did not result in altered endothelin ETB receptor mediated 
contractions (E
max
 in % of 60 mM K+: organ culture with water = 111 ± 6, organ culture with 25 ng 
WSS = 81 ± 12, and organ culture with 250 ng WSS = 101 ± 28) (Figure 1A, Table 2). There was a 
tendency towards a weaker contraction by 25 ng WSS after organ culture and a slightly lower ETB 
receptor mRNA (Figure 2A), however, without significance. The ETB receptor protein level 
remained stable (Figure 3A). There was no alteration in the S6c pEC50 values. 
 
The 5-HT1B and 5-HT2A receptor mediated contraction were altered by WSS. Whereas 25 ng WSS 
reduced the 5-CT contraction of the vessels, 250 ng WSS increase the contraction (E
max(2) in  % of 
60 mM K+: organ culture with water = 60 ± 6, organ culture with 25 ng WSS = 28 ± 3, and organ 
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culture with 250 ng WSS = 114 ± 8) (Figure 1B, Table 2) (p<0.05 for both doses). The 5-HT1B 
receptor mRNA and protein levels in the 25 ng WSS group and the 250 ng WSS group remained 
unaffected (Figure 2B and 3B). The 5-CT pEC50(2) values did change in the WSS incubations 
(pEC50(2) values of 5-CT: organ culture with  water = 5.9 ± 0.1, organ culture with 25 ng WSS = 
6.9 ± 0.1, and organ culture with 250 ng WSS = 7.8 ± 0.1)(Table 2) (p<0.01 for the high dose).  
 
The TP receptor mediated contraction was not affected by WSS (Emax in % of 60 mM K+: organ 
culture with water = 161 ± 12, organ culture with 25 ng WSS = 142 ± 6, and organ culture with 250 
ng WSS = 164 ± 16)(Figure 1C, Table 2). In addition, mRNA and protein levels of TP receptors did 
not change by adding WSS (Figure 2C, 3C). The U46619 pEC50 values in the high dose increased 
by addition of WSS to the organ culture (pEC50 values of U46619: organ culture with water = 7.6 ± 
0.2, organ culture with 25 ng WSS = 7.9 ± 0.1, and organ culture with 250 ng WSS = 8.3 ± 0.1) 
(Table 2) (p<0.01 for high dose).  
 
3.3.2 Nicotine 
Addition of nicotine in the high dose increased the ETB receptor mediated contraction significantly 
(Emax in % of 60 mM K+: organ culture with water = 111 ± 6, organ culture with 25 ng nicotine = 
99 ± 9, and organ culture with 250 ng nicotine = 132 ± 9) (Figure 1D, Table 2) (p<0.05). This 
increased contraction induced by S6c could not be explained by real time PCR or 
immunohistochemistry (Figure 2D, 3D). Real time PCR showed a significant drop in the ETB 
receptor mRNA level at the “normal” nicotine dose (25 ng) (p<0.001) in stead. This drop did 
however not affect the contraction induced by S6c. The S6c pEC50 values did not change by 
addition of nicotine in the organ culture. 
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The 5-CT induced concentration-effect curve was significantly increased by the high dose of 
nicotine (E
max
 in % of 60 mM K+: organ culture with water = 60 ± 6, organ culture with 25 ng 
nicotine = 83 ± 6, and organ culture with 250 ng nicotine = 97 ± 14) (Figure 1E, Table 2) (p<0.05 
for high dose). Real time PCR showed a significant drop in 5-HT1B receptor mRNA level in the 25 
ng nicotine group (Figure 2E) (p<0.001), whereas the protein levels remained unaffected at either 
dose of nicotine (Figure 3E). The 5-CT pEC50(2) value increased by the higher dose of nicotine 
(pEC50(2) values of 5-CT: organ culture with water = 5.9 ± 0.1, organ culture with 25 ng nicotine = 
6.0 ± 0.1, and organ culture with 250 ng nicotine = 7.7 ± 0.2) (Table 2) (p<0.01 for high dose). The 
increased pEC50(2) value at the high nicotine dose shows that less 5-CT is needed to induce the 
same contraction when exposed to 250 ng nicotine.  
 
The TP receptor mediated contraction was stable and not affected by nicotine (Emax in % of 60 
mM K+: organ culture with water = 161 ± 12, organ culture with 25 ng nicotine = 161 ± 14, and 
organ culture with 250 ng nicotine = 161 ± 8) (Figure 1F, Table 2). Real time PCR showed a 
significant drop in the TP receptor mRNA level (Figure 2F) (P<0.001), but this drop did not affect 
the U46619 contraction. Protein levels remained unaffected (Figure 3F). The U46619 pEC50 values 
did change by addition of nicotine to the organ culture (pEC50 values of U46619: organ culture 
with water = 7.6 ± 0.2, organ culture with 25 ng nicotine = 7.6 ± 0.1, and organ culture with 250 ng 
nicotine = 8.0 ± 0.1) (Table 2) (p<0.01 for high dose). 
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3.3.3 DMSO (lipid) - soluble snus (DSS) 
The ETB receptor mediated contraction was not affected by DSS (Emax in % of 60 mM K+: organ 
culture with DMSO = 80 ± 12, organ culture with 25 ng DSS = 86 ± 9, and organ culture with 250 
ng DSS = 86 ± 9) (Figure 1G, Table 2). Real time PCR showed a significant increase in the ETB 
receptor mRNA level (Figure 2G) (P<0.001). The S6c induced contraction and the receptor protein 
level remained unaffected (Figure 3G).  
 
The 5-CT curve was significantly altered in both DSS dose groups (Emax(2) in % of 60 mM K+: 
organ culture with DMSO = 64 ± 7, organ culture with 25 ng DSS = 35 ± 14, and organ culture with 
250 ng DSS = 98 ± 11) (Figure 1H, Table 2) (p<0.05). This correlates well with the real time PCR 
results with a significant rise in the 5-HT1B receptor mRNA level in the 250 ng DSS group (Figure 
2H) (p<0.001), while the 25 ng DSS group remained. The protein levels remained unaffected 
(Figure 3H). The 5-CT pEC50(2) values were affected by DSS (pEC50(2) values of 5-CT: organ 
culture with DMSO = 5.9 ± 0.1, organ culture with 25 ng DSS = 5.9 ± 0.1, and organ culture with 
250 ng DSS = 6.5 ± 0.1) (Table 2) (p<0.01 for high dose). 
 
The TP receptor mediated contractions (Emax in % of 60 mM K+: organ culture with DMSO = 137 
± 9, organ culture with 25 ng DSS = 156 ± 11, and organ culture with 250 ng DSS = 156 ± 12) 
(Figure 1I, Table 2), were not statistically modified. This agrees with no effect TP receptor mRNA 
(Figure 2I) (but not significant) and immunohistochemical TP receptor protein level (Figure 3I). 
There was a significant increase in U46619 pEC50 values by DSS (pEC50 values of U46619: OC 
DMSO = 7.6 ± 0.1, OC DSS 25 ng = 8.1 ± 0.1, and OC DSS 250 ng = 8.1 ± 0.1) (Table 2) (p<0.01 
for both doses).  
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4 Discussion  
Smokeless tobacco (Swedish moist 'snus') users are often strongly addicted to nicotine (verified by 
several of smoking-cessation studies), because the amount of nicotine measured in the blood is at 
much higher level, as compared to that seen in cigarette smokers. The present study demonstrates, 
for the first time, that water- or DMSO-soluble snus alter the GPCR expression in rat cerebral 
arteries for endothelin ETB, serotonin 5-HT1B, and thromboxane TP. This may suggest a potential 
impact of nicotine and snus on the development of cerebrovascular disease. 
 
There is an increased expression of ETB receptors in stroke, which is associated with reduced 
cerebral flow and cerebral ischemia (Ansar et al., 2007;Hansen-Schwartz et al., 2003b). In the 
present study, we have shown that the expression of the ETB receptor did not change when exposed 
to the normal plasma nicotine level (25 ng nicotine/ml seen in snus users), except for reduced ETB 
receptor mRNA when nicotine was added to organ culture, and increased ETB receptor mRNA 
when DSS was added. On the other hand, a high dose of nicotine (250 ng nicotine /ml) increased 
the ETB receptor mediated contraction of cerebral arteries. This gives a caution for using high dose 
of nicotine.  
 
In previous studies, we demonstrated that in experimental stroke models, 5-HT receptors were 
involved in the pathogenesis, with increased 5-HT receptor-mediated contractions (Hansen-
Schwartz et al., 2003a). 5-HT receptors mediate strong cerebral vessel contractions and the 
alteration of the serotonin receptor expression is seen after cerebral ischemia (Hansen-Schwartz et 
al., 2003a) or when vessels are exposed to lipid-soluble cigarette smoke extract (Zhang et al., 
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2009). Here, snus and nicotine also induced alteration of the 5-HT1B and 5-HT2A receptor-
mediated. In the normal dose of plasma level of nicotine WSS and DSS decreases the Emax(2) of 
the 5-CT curve, while high nicotine dose of WSS, DSS, and nicotine increased the Emax(2) of the 
5-CT curve even though the 5-HT1B receptor mRNA was reduced in the DSS group. This is in line 
with the present findings that the high dose of WSS, DSS, or nicotine also shifted the 5-CT curve 
left-wards to the high affinity part.  
 
TP receptor density is enhanced in cardiovascular diseases (Katugampola et al., 2001)  and in 
hypertension (Geoffroy et al., 1989). This increase is likely to be associated with an increase in risk 
for cardiovascular disease. In addition to being a potent vasoconstrictor TxA2 also stimulates 
platelet aggregation, migration, proliferation, and smooth muscle cell differentiation by activating 
the TP receptor, with molecular mechanisms might be mediated through the ERK and p38 MAPK 
(Huang et al., 2004;Morinelli et al., 1994;Yun et al., 2009). In addition to this, we found in the 
present study, that the normal dose of DSS and high dose of WSS, DSS, and nicotine shifted the TP 
receptor mediated curve left-wards, while the normal plasma dose of nicotine lowered the TP 
receptor mRNA.  
 
Cigarette smoke is a independent risk factor for stroke. Sweden has much less smokers, and only 
17% of Swedish men smoke, because Swedes use another form of moist tobacco called “Snus” 
instead (Foulds et al., 2003;Haglund et al., 2007). Epidemiological studies have failed to find 
evidence that moist snus causes cancers, while the adverse effects of snus on the cardiovascular 
system are debated. Previously, we have demonstrated that there is upregulation of GPCR 
expression in cardiovascular disease, which leads to an abnormal smooth muscle cell contraction 
and proliferation, key events in cardiovascular pathology. The change in receptor phenotype can 
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experimentally be mimicked by organ culture of the arteries in serum-free medium (Hansen-
Schwartz et al., 2002;Hoel et al., 2001). Following organ culture of the arteries, there is a time-
dependent increase in ETB receptor mRNA, which is followed by increased levels of ETB receptor 
protein and function (Hansen-Schwartz et al., 2002;Sandhu et al., 2010a). Recently, we have 
reported that organ culture of rat cerebral arteries induced upregulation of ETB and TP receptors and 
this receptor upregulation was further increased by DMSO-soluble cigarette smoke extract, but not 
water-soluble cigarette smoke extract (Sandhu et al., 2010b;Sandhu et al., 2010c). The molecular 
mechanisms involved are associated with activation of MAPK-mediated intracellular signal 
pathways. However, using the same model, we have failed to demonstrate this phenomenon of the 
ETB and TP receptor upregulation by DMSO-soluble snus extract, suggesting snus may have less 
effect than cigarette smoke or it may act through different molecular mechanisms. Snus does 
however increase blood pressure (Hergens et al., 2008) and the outcome of fatal diseases (Hergens 
et al., 2007). Therefore snus may influence the severity of vascular disease indirectly. 
 
5 Conclusion 
In conclusion, we found when cerebral arteries are exposed to extracts from snus or nicotine there 
was an alteration of the GPCR’s (5-HT1B and 5-HT2A, ETB, and TP) receptor-mediated 
contractions. Normal nicotine plasma level of WSS and DSS decreased the 5-HT1B and 5-HT2A 
contraction and left-wards shifted the TP contraction curve, however, this increase was not 
explained by real time PCR or protein immunohistochemistry, which failed to show an increased 
mRNA and protein expressions for the GPCR. High nicotine level of WSS, DSS, or nicotine 
increased the 5-CT mediated contraction curve and left-wards shifted the TP contraction curve. 
Only the DSS group showed that the increase of the 5-CT curve was at the mRNA level. This 
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suggests that both transcriptional and post-translational mechanisms are responsible for the 5-HT 
receptor alteration by WSS, DSS, or nicotine. High nicotine level increased the ETB mediated 
contraction curve. The alteration of GPCR expression by snus and nicotine in the cerebral arteries is 
most likely a molecular mechanism, which is responsible for inducing cerebral vascular damage. 
Thus, this suggests that snus and nicotine may have potential impact on cerebral vasculature and on 
the development of cardiovascular diseases.    
 
6 Conflict of interest 
Authors declare not having any financial or personal interest, nor having an association with any 
individuals or organizations that could have influenced inappropriately the submitted work. 
 
7 Acknowledgements 
This work was financially supported by the Danish Research Council, the Lundbeck Foundation 
(LUCENS, Denmark), the Swedish Research Council (grant no 5958), and Flight Attendant 
Medical Research Institute (FAMRI, USA). 
 
8 References 
 1.  Andersson, G., Bjornberg, G., and Curvall, M. (1994). Oral mucosal changes and nicotine 
disposition in users of Swedish smokeless tobacco products: a comparative study. J Oral 
Pathol.Med. 23, 161-167. 
 2.  Ansar, S., Vikman, P., Nielsen, M., and Edvinsson, L. (2007). Cerebrovascular ETB, 5-HT1B, 
and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid 
hemorrhage. Am.J.Physiol Heart Circ.Physiol 293, H3750-H3758. 
 23 
 3.  Benowitz, N. L., Jacob, P., III, Fong, I., and Gupta, S. (1994). Nicotine metabolic profile in 
man: comparison of cigarette smoking and transdermal nicotine. J.Pharmacol Exp.Ther. 268, 
296-303. 
 4.  Bolinder, G. M., Ahlborg, B. O., and Lindell, J. H. (1992). Use of smokeless tobacco: blood 
pressure elevation and other health hazards found in a large-scale population survey. J 
Intern.Med. 232, 327-334. 
 5.  Coleman, R. A., Smith, W. L., and Narumiya, S. (1994). International Union of Pharmacology 
classification of prostanoid receptors: properties, distribution, and structure of the receptors 
and their subtypes. Pharmacol Rev 46, 205-229. 
 6.  Foulds, J., Ramstrom, L., Burke, M., and Fagerstrom, K. (2003). Effect of smokeless tobacco 
(snus) on smoking and public health in Sweden. Tob.Control 12, 349-359. 
 7.  Geoffroy, J., Benzoni, D., and Sassard, J. (1989). Antihypertensive effect of thromboxane A2 
receptor blockade in genetically hypertensive rats of the Lyon strain. J Hypertens.Suppl 7, 
S272-S273. 
 8.  Haglund, B., Eliasson, M., Stenbeck, M., and Rosen, M. (2007). Is moist snuff use associated 
with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand.J 
Public Health 35, 618-622. 
 9.  Hansen-Schwartz, J., Hoel, N. L., Xu, C. B., Svendgaard, N. A., and Edvinsson, L. (2003a). 
Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in 
rats. J Neurosurg 99, 115-120. 
 10.  Hansen-Schwartz, J., Hoel, N. L., Zhou, M., Xu, C. B., Svendgaard, N. A., and Edvinsson, L. 
(2003b). Subarachnoid hemorrhage enhances endothelin receptor expression and function in 
rat cerebral arteries. Neurosurgery 52, 1188-1194. 
 11.  Hansen-Schwartz, J., Svensson, C. L., Xu, C. B., and Edvinsson, L. (2002). Protein kinase 
mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D 
receptors during organ culture in rat basilar artery. Br.J.Pharmacol 137, 118-126. 
 12.  Henriksson, M., Stenman, E., and Edvinsson, L. (2003). Intracellular pathways involved in 
upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 34, 
1479-1483. 
 13.  Hergens, M. P., Alfredsson, L., Bolinder, G., Lambe, M., Pershagen, G., and Ye, W. (2007). 
Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J 
Intern.Med. 262, 351-359. 
 14.  Hergens, M. P., Lambe, M., Pershagen, G., and Ye, W. (2008). Risk of hypertension amongst 
Swedish male snuff users: a prospective study. J Intern.Med. 264, 187-194. 
 15.  Hoel, N. L., Hansen-Schwartz, J., and Edvinsson, L. (2001). Selective up-regulation of 5-
HT(1B/1D) receptors during organ culture of cerebral arteries. Neuroreport 12, 1605-1608. 
 24 
 16.  Hogestatt, E. D., Andersson, K. E., and Edvinsson, L. (1983). Mechanical properties of rat 
cerebral arteries as studied by a sensitive device for recording of mechanical activity in 
isolated small blood vessels. Acta Physiol Scand 117, 49-61. 
 17.  Huang, J. S., Ramamurthy, S. K., Lin, X., and Le Breton, G. C. (2004). Cell signalling 
through thromboxane A2 receptors. Cell Signal. 16, 521-533. 
 18.  Katugampola, S. D., and Davenport, A. P. (2001). Thromboxane receptor density is increased 
in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by 
the AT(1) receptor antagonist losartan. Br.J Pharmacol 134, 1385-1392. 
 19.  Masaki, T., Vane, J. R., and Vanhoutte, P. M. (1994). International Union of Pharmacology 
nomenclature of endothelin receptors. Pharmacol Rev 46, 137-142. 
 20.  Morinelli, T. A., Zhang, L. M., Newman, W. H., and Meier, K. E. (1994). Thromboxane 
A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves 
activation of mitogen-activated protein kinase and S6 kinase. J Biol.Chem. 269, 5693-5698. 
 21.  Mulvany, M. J., and Halpern, W. (1977). Contractile properties of small arterial resistance 
vessels in spontaneously hypertensive and normotensive rats. Circ Res 41, 19-26. 
 22.  Nilsson, T., Longmore, J., Shaw, D., Olesen, I. J., and Edvinsson, L. (1999). Contractile 5-
HT1B receptors in human cerebral arteries: pharmacological characterization and localization 
with immunocytochemistry. Br.J Pharmacol 128, 1133-1140. 
 23.  Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, 
M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., 
Nichol, G., O'Donnell, C., Roger, V., Sorlie, P., Steinberger, J., Thom, T., Wilson, M., and 
Hong, Y. (2008). Heart disease and stroke statistics--2008 update: a report from the American 
Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, 
e25-146. 
 24.  Sandhu, H. K., Ansar, S., and Edvinsson, L. (2010a). Comparison of MEK/ERK pathway 
inhibitors on the upregulation of vascular G protein coupled receptors in rat cerebral arteries. 
Eur J Pharmacol 644, 128-137. 
 25.  Sandhu, H. K., Xu, C. B., and Edvinsson, L. (2010b). Upregulation of contractile endothelin 
type B2 receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via 
activation of MAPK. Toxicology and Applied Pharmacology In press. 
 26.  Sandhu, H. K., Xu, C. B., and Edvinsson, L. (2010c). Upregulation of contractile prostanoid 
TP receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via 
posttranscriptional mechanisms. Basic & Clinical Pharmacology & Toxicology In press. 
 27.  US Department of Health and Human Services (1986). The health consequences of using 
smokeless tobacco. A report of the advisory committee to the Surgeon General. Bethesda, 
Maryland: Public Health Service, National Institutes of Health (NIH publication No 86-2874. 
 25 
 28.  Yun, D. H., Song, H. Y., Lee, M. J., Kim, M. R., Kim, M. Y., Lee, J. S., and Kim, J. H. 
(2009). Thromboxane A(2) modulates migration, proliferation, and differentiation of adipose 
tissue-derived mesenchymal stem cells. Exp.Mol.Med. 41, 17-24. 
 29.  Zhang, J. Y., Cao, L., Zheng, X. H., Xu, C. B., and Cao, Y. X. (2009). Dimethylsulfoxide-
soluble smoking particles and nicotine affect vascular contractibility. Arch.Pharm.Res. 32, 
1475-1481. 
 
 
Figure 1 
Contractile response to the cumulative application of S6c, 5-CT, or U46619 to fresh or incubated 
middle cerebral arteries with vehicle (Water or DMSO) or WSS (A-C), Nicotine (D-F), or DSS (G-
I). Values given represent means ± S.E.M. (n = 6-10). Statistical values for myograph experiments 
are given in Table 2. 
 
Figure 2 
Real time PCR of fresh or incubated middle cerebral arteries with vehicle (Water or DMSO) or 
WSS (A-C), Nicotine (D-F), or DSS (G-I). Data are expressed as mean ± S.E.M. values relative to 
EF-1 mRNA levels (n= 6-7). Comparison of values were done fresh versus organ culture 24 h with 
vehicle (water or DMSO), 24 h organ culture with water vehicle versus WSS (25 ng/ml or 250 
ng/ml) or nicotine (25 ng/ml or 250 ng/ml), and 24 h organ culture with DMSO vehicle versus DSS 
(25 ng/ml or 250 ng/ml). Statistical analysis: * = p<0.05,  ** = p<0.01, and *** = p<0.001. 
 
Figure 3 
Immunohistochemistry staining against endothelin ETB , serotonin 5-HT1B, or prostanoid TP 
receptor and actin of fresh or incubated middle cerebral arteries with vehicle (Water or DMSO) or 
WSS (A-C), Nicotine (D-F), or DSS (G-I). Green channel (488 nm, receptor staining) and green-red 
channel merge (488 nm and 549 nm, receptor and actin staining) images are shown in J) as an 
example for the endothelin ETB receptor staining in the WSS group (100x lense). Data are 
expressed as mean ± s.e.m. (n= 4-5). Comparison of values were done fresh versus organ culture 24 
h with vehicle (water or DMSO), 24 h organ culture with water vehicle versus WSS (25 ng/ml or 
250 ng/ml) or nicotine (25 ng/ml or 250 ng/ml), and 24 h organ culture with DMSO vehicle versus 
DSS (25 ng/ml or 250 ng/ml). Statistical analysis: * = p<0.05,  ** = p<0.01, and *** = p<0.001. 
Figure legends
  
Fresh OC Water OC DMSO 
60 mM K+ in mN  4.39±1.45 4.18±1.75 3.84±1.64 
Endothelium in % of CA dilatation  52 ± 10 28 ± 8 27 ± 2 
S6c Emax in % of K+ 5 ± 1 c  111 ± 6 80 ± 12  
 pEC50 - 10.8 ± 0.2 10.6 ± 0.3 
5-CT (low affinity) Emax in % of K+ 5 ± 2 4 ± 1  8 ± 4 
 pEC50 - - - 
5-CT (high affinity) Emax in % of K+ 52 ± 14 60 ± 6 64 ± 7 
 pEC50 5.8 ± 0.1 5.9 ± 0.1 5.9 ± 0.1 
U46619 Emax in % of K+ 152 ± 13 161 ± 12 137 ± 9 
 
pEC50 7.2 ± 0.1 7.6 ± 0.2 7.6 ± 0.1 
  
OC WSS 25 ng OC WSS 250 ng 
 
60 mM K+ in mN  3.44 ±1.37 3.41±1.67 
 
Endothelium in % of CA dilatation 35 ± 4 21 ± 3 
 
S6c Emax in % of K+ 81 ± 12 101 ± 28 
 
 pEC50 10.5 ± 0.3 10.5 ± 0.4 
 
5-CT (low affinity) Emax in % of K+  6 ± 2 37 ± 12  
 
 pEC50 - 7.8 ± 0.6 
 
5-CT (high affinity) Emax in % of K+ 28 ± 3 a 114 ± 8 a 
 
 pEC50 6.9 ± 0.1 7.8 ± 0.1 b 
 
U46619 Emax in % of K+ 142 ± 6 164 ± 16  
 
pEC50 7.9 ± 0.1 8.3 ± 0.1 b 
 
  
OC Nicotine 25 ng OC Nicotine 250 ng 
 
60 mM K+ in mN  3.44±1.37 2.99±1.02 
 
Endothelium in % of CA dilatation 22 ± 3 22 ± 3 
 
S6c Emax in % of K+ 99 ± 9 132 ± 9 a 
 
 pEC50 10.8 ± 0.2 10.4 ± 0.2 
 
5-CT (low affinity) Emax in % of K+ 40 ± 14 48 ± 19 
 
 pEC50 6.1 ± 1 7.7 ± 0.4 
 
5-CT (high affinity) Emax in % of K+ 83 ± 6 97 ± 14 a 
 
 pEC50 6.0 ± 0.1 7.7 ± 0.2 b 
 
U46619 Emax in % of K+ 161 ± 14 161 ± 8  
 
pEC50 7.6 ± 0.1 8.0 ± 0.1 b 
 
  
OC DSS 25 ng OC DSS 250 ng 
 
60 mM K+ in mN  3.77±1.34 3.11±1.19 
 
Endothelium in % of CA dilatation 23 ± 4 25 ± 5 
 
S6c Emax in % of K+ 86 ± 9 86 ± 9 
 
 pEC50 10.7 ± 0.2 10.7 ± 0.2 
 
5-CT (low affinity) Emax in % of K+ 12 ± 7 19 ± 12  
 
 pEC50 - 7.1 ± 1.7 
 
5-CT (high affinity) Emax in % of K+ 35 ± 14 a 98 ± 11 a 
 
 pEC50 5.9 ± 0.1 6.5 ± 0.1 b 
 
U46619 Emax in % of K+ 156 ± 11  165 ± 7   
 
pEC50 8.1 ± 0.1 b 8.2 ± 0.1 b 
 
Table 1
Table 1 – Emax and pEC50 values of fresh or 24 h incubated (OC = organ culture) middle cerebral 
artery with vehicle (Water or DMSO) or WSS, Nicotine, or DSS. Endothelium in % of CA 
dilatation is the value of 10 µM carbachol (CA) dilatation of 300 nM 5-HT pre-contracted vessels. 
Values are given for all agonist experiments as mean ± S.E.M. Low and high affinity Emax and 
pEC50 values are given for 24 h organ culture of middle cerebral artery 5-CT biphasic sigmoid 
curve. Comparison of values were done fresh versus organ culture 24 h with vehicle (water or 
DMSO), 24 h organ culture with water vehicle versus WSS (25 ng/ml or 250 ng/ml) or nicotine (25 
ng/ml or 250 ng/ml), and 24 h organ culture with DMSO vehicle versus DSS (25 ng/ml or 250 
ng/ml). Statistical analysis: a p<0.05 and b p<0.01, and c p<0.001. S6c = sarafotoxin 6c, and 5-CT 
= 5-carboxamidotryptamine.  
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